nimble_asset_Website-banner-Assessments

TIMELINE OF ASSESSMENT

The table below shows the Timeline for Major Applications – General HTA track.

 

HEALTH TECHNOLOGY LAPATINIB FOR HER2(+) BC TACE WITH MITOMYCIN C ZOLEDRONIC ACID CEREBROLYSIN INSULIN ANALOGUES NEW OHA (DPP4 AND SGLT2 INHIBITORS: Sitagliptin and Dapagliflozin) DEXAMETHASONE IMPLANT DIRECT ORAL ANTICOAGULANTS CITICOLINE TIROFIBAN TICAGRELOR (90 MG) IVABRADINE
PROPONENT PSVIR NKTI SSP PSEDM PSEDM PAO PNA PNA PSCCI PHC PHA
TOPIC NOMINATION 19 February 2019 08 February 2019 08 November 2018 24 January 2017 07 September 2016 July 2018 31 January 2019 31 January 2019 30 January 2019 31 January 2019
TOPIC PRIORITIZATION
SCOPING -present 07 May 2021 - present 31 March 2021 - 14 April 2021 11 May 2021 - present 11 May 2021 - present
PROTOCOL DEVELOPMENT 15 April 2021 - 21 May 2021
CLINICAL ASSESSMENT 21 May 2021 Present 30 March 2021 - 30 May 2021
ECONOMIC ASSESSMENT 31 May 2021 - present
EVIDENCE APPRAISAL
RECOMMENDATION 07 May 2021 - present
APPEALS
RESOLUTION
DECISION
DISSEMINATION